ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,210, issued on Sept. 23, was assigned to New York University (New York).

"Fused bicyclic heterocycles as therapeutic agents" was invented by John K. Dickson (Apex, N.C.), Andrew S. Chi (New York), Xinyan Huang (Paramus, N.J.) and Nadim Shohdy (Garden City, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to nicotinamide phosphoribosyltransferase (NAM FT) expression. More particularly, this disclosure relates to fused bicyclic heterocyclic compounds and pharmaceutical compositions the...